• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Live attenuated Salmonella vaccines and their potential as oral combined vaccines carrying heterologous antigens.

作者信息

Hormaeche C E

机构信息

Department of Pathology, Cambridge, U.K.

出版信息

J Immunol Methods. 1991 Aug 28;142(1):113-20. doi: 10.1016/0022-1759(91)90298-t.

DOI:10.1016/0022-1759(91)90298-t
PMID:1919015
Abstract

Live attenuated salmonellae are protective, and are candidate vaccines against invasive salmonella infections in man and animals. Different attenuating mutations have been described, and more than one can be incorporated in a vaccine for added safety. Combined salmonella vaccines express target carbohydrate and protein antigens or epitopes from viruses, bacteria and eukaryotic parasites, either within or on the surface of the cell, as capsules, fimbriae, or in the flagellin. Humoral, secretory and cellular responses to the recombinant antigens has been demonstrated. Experimental protection against diseases including streptococcal infection, tetanus, influenza and malaria has been obtained.

摘要

相似文献

1
Live attenuated Salmonella vaccines and their potential as oral combined vaccines carrying heterologous antigens.
J Immunol Methods. 1991 Aug 28;142(1):113-20. doi: 10.1016/0022-1759(91)90298-t.
2
Live oral Salmonella vaccines: potential use of attenuated strains as carriers of heterologous antigens to the immune system.活口服沙门氏菌疫苗:减毒株作为异源抗原载体对免疫系统的潜在应用。
Parasite Immunol. 1987 Mar;9(2):151-60. doi: 10.1111/j.1365-3024.1987.tb00496.x.
3
Recombinant Salmonella vectors in vaccine development.疫苗研发中的重组沙门氏菌载体
Dev Biol Stand. 1994;82:23-33.
4
Salmonellae as oral vaccine carriers.沙门氏菌作为口服疫苗载体。
Dev Biol Stand. 1995;84:245-53.
5
Live Salmonella as vaccines and carriers of foreign antigenic determinants.
Vaccine. 1989 Dec;7(6):495-8. doi: 10.1016/0264-410x(89)90271-5.
6
Live-attenuated Salmonella as a prototype vaccine vector for passenger immunogens in humans: are we there yet?减毒活沙门氏菌作为人类中携带免疫原的原型疫苗载体:我们做到了吗?
Expert Rev Vaccines. 2007 Jun;6(3):431-40. doi: 10.1586/14760584.6.3.431.
7
The development of oral vaccines based on live attenuated Salmonella strains.基于减毒活沙门氏菌菌株的口服疫苗的研发。
FEMS Immunol Med Microbiol. 1993 Jun;7(1):1-7. doi: 10.1111/j.1574-695X.1993.tb00374.x.
8
Delivery of heterologous protein antigens via hemolysin or autotransporter systems by an attenuated ler mutant of rabbit enteropathogenic Escherichia coli.兔肠道致病性大肠杆菌的减毒ler突变体通过溶血素或自转运蛋白系统递送异源蛋白抗原。
Vaccine. 2006 May 1;24(18):3821-31. doi: 10.1016/j.vaccine.2005.07.024. Epub 2005 Jul 25.
9
Expression of hepatitis B virus antigens in attenuated Salmonellae for oral immunization.用于口服免疫的减毒沙门氏菌中乙型肝炎病毒抗原的表达
Res Microbiol. 1990 Sep-Oct;141(7-8):831-7. doi: 10.1016/0923-2508(90)90118-a.
10
The development of oral vaccines against parasitic diseases utilizing live attenuated Salmonella.利用减毒活沙门氏菌开发抗寄生虫病的口服疫苗。
Parasitology. 1995;110 Suppl:S17-24. doi: 10.1017/s0031182000001451.

引用本文的文献

1
Assessment of microbiological correlates and immunostimulatory potential of electron beam inactivated metabolically active yet non culturable (MAyNC) Salmonella Typhimurium.评估电子束灭活代谢活跃但不可培养(MAyNC)鼠伤寒沙门氏菌的微生物相关性和免疫刺激潜力。
PLoS One. 2021 Apr 16;16(4):e0243417. doi: 10.1371/journal.pone.0243417. eCollection 2021.
2
Refinement of a Live Attenuated Serovar Newport Vaccine with Improved Safety.一种安全性得到改善的减毒活新港血清型疫苗的优化
Vaccines (Basel). 2021 Jan 16;9(1):57. doi: 10.3390/vaccines9010057.
3
Live vaccination tactics: possible approaches for controlling visceral leishmaniasis.
活疫苗接种策略:控制内脏利什曼病的可能方法。
Front Immunol. 2014 Mar 31;5:134. doi: 10.3389/fimmu.2014.00134. eCollection 2014.
4
Bacteria as vectors for gene therapy of cancer.细菌作为癌症基因治疗的载体。
Bioeng Bugs. 2010 Nov-Dec;1(6):385-94. doi: 10.4161/bbug.1.6.13146.
5
Safety and immunogenicity of Salmonella typhimurium expressing C-terminal truncated human IL-2 in a murine model.在小鼠模型中表达C端截短型人白细胞介素-2的鼠伤寒沙门氏菌的安全性和免疫原性。
Biologics. 2010 Mar 24;4:61-73. doi: 10.2147/btt.s9121.
6
DNA-Salmonella enterica serovar Typhimurium primer-booster vaccination biases towards T helper 1 responses and enhances protection against Leishmania major infection in mice.DNA-鼠伤寒沙门氏菌血清型鼠伤寒疫苗初免-加强免疫偏向于辅助性T细胞1反应,并增强小鼠对硕大利什曼原虫感染的抵抗力。
Infect Immun. 2004 Aug;72(8):4924-8. doi: 10.1128/IAI.72.8.4924-4928.2004.
7
Genetic control of immune response to recombinant antigens carried by an attenuated Salmonella typhimurium vaccine strain: Nramp1 influences T-helper subset responses and protection against leishmanial challenge.减毒鼠伤寒沙门氏菌疫苗株携带的重组抗原免疫应答的遗传控制:Nramp1影响辅助性T细胞亚群应答及对利什曼原虫攻击的抵抗力。
Infect Immun. 1998 May;66(5):1910-7. doi: 10.1128/IAI.66.5.1910-1917.1998.
8
Isolation and characterization of a cloned Porphyromonas gingivalis hemagglutinin from an avirulent strain of Salmonella typhimurium.从鼠伤寒沙门氏菌无毒株中克隆牙龈卟啉单胞菌血凝素的分离与鉴定
Infect Immun. 1993 Mar;61(3):940-6. doi: 10.1128/iai.61.3.940-946.1993.
9
Listeria monocytogenes p60 supports host cell invasion by and in vivo survival of attenuated Salmonella typhimurium.单核细胞增生李斯特菌p60支持减毒鼠伤寒沙门氏菌侵袭宿主细胞并在体内存活。
Infect Immun. 1995 May;63(5):2047-53. doi: 10.1128/iai.63.5.2047-2053.1995.